Our Story

We had enough.

Mymee was conceived after years of feeling sick, alone and disempowered by a healthcare system that simply did not understand the nuanced challenges of autoimmune disorders.

Creating a mirror image

Understanding me.

The origin of the name “Mymee” came from the idea that our application would essentially “mime” a person, providing a clear mirror image of themselves. From the very beginning, we knew that if we could capture a body’s signals and decode the hidden patterns, we could create the world’s first truly personalized approach to health optimization.

Rethinking Autoimmunity

The evolution into digital therapeutics.

The evolution from an idea into the first medication-free autoimmunity solution happened quite quickly. Within just a few years and lots of elbow grease, we had established the backend technology and data algorithms to allow Mymee to deliver a one-to-one solution to hundreds of users. We established an advisory board of Rheumatologists, Technology Leaders and Functional Medicine practitioners and built a team to support the commercial and clinical strategy.

Everybody wins

Forging the future of healthcare.

As we put Mymee through the paces clinically and commercially, it became clear that it was our responsibility to bring our solution to as many sufferers as we could. Our vision is to develop the world’s first biomarker for autoimmunity, allowing us to identify individuals who are heading toward autoimmunity and put them on the path to circumvent the years of suffering and expense that awaits them. Through early intervention, we believe that we can lower the cost curve of healthcare in this country which benefits everyone across the board.

Mymee Fast Facts

2017

Year founded

1,000

empower-black

Participants Helped

89

NPS Score

90

percent-black

program completion rate

2017

Year founded

1,000

empower-black

Participants Helped

89

NPS Score

90

percent-black

program completion rate

ceo

Mette Dyhrberg.

Mette is a digital health innovator committed to improving the quality of life for those with chronic disease. She is the founder and CEO of Mymee.

mette - no background

Executive team.

We believe in the power of Mymee, because we’re patients, just like you. And we’re dedicated to building technology to combat today’s generic autoimmune treatments.

eric.

CTO

marie.

COO

robyn.

VP of Marketing

mara.

General Counsel

Nicole.

Chief Medical Officer

Millennia.

Head of Coaching

Martin.

SVP Scientific & Regulatory Affairs

We're proud to have been featured in these publications

motherjones
healthtech-conference
mdicineX
bbc-one
san-francisco-chronicle
smithsonian
newscientist
self
npr
the-wall-street-journal